生物技術開發中心 | Technology Promotion
|
No. |
Name |
Type |
Devt. Phase /Application |
Slide Deck |
|
1 |
PD-L1/CSF-1R Antibody in Preclinical Studies for Cancer Immunotherapy |
Biologics |
Preclinical Testing/ Validation Optimization |
|
|
2 |
Development of Novel ADC Targeting Neurotensin receptor-1 (NTSR1) for Head and Neck Cancer Therapy |
ADC |
Preclinical Testing |
|
|
3 |
A Site-Specific Antibody-Drug Conjugate Targeting B7-H3 for Cancer Therapy |
ADC |
Preclinical Testing |
|
|
4 |
A Selective & Orally Active Raf Kinase Inhibitor as a Precision Medicine |
Small Molecule |
IND Ready |
|
|
5 |
Development of Novel Selective FPR1 Antagonist Against Neutrophil Related Inflammatory Disease |
Small Molecule |
Preclinical Testing |
|
|
6 |
Targeting Idiopathic Pulmonary Fibrosis: Development of a TXNDC5 Oligonucleotide Drug |
Oligonucleotide |
Preclinical Testing |
|
|
7 |
The Next-Generation in vivo CAR-T Therapy |
Platform |
Cell Therapy Platform |
|
|
8 |
Rejuvenating CAR-T Cells through the Secretion of Antibodies Targeting Immunosuppressive Axis |
Biologics/ Platform |
Preclinical Testing |
|
|
9 |
LYSwardTM: The Generation of a pH-Dependent Antibody Drug Conjugate to Enhance Antitumor Activity |
Platform |
ADC Platform |
|
|
10 |
Human Synthetic Antibody Library for Therapeutic Drug Discovery |
Platform |
Antibody Production |
|
|
11 |
The High Yield Therapeutic mRNA Production Platform |
Platform |
mRNA Production |
|
|
12 |
A Liver-targeted LNP Platform for PKU Therapy |
Platform |
LNP Platform |
|
|
13 |
An SLO-targeted Adjuvant LNP Platform: Enabling Ultra-Low-Dose Cancer Vaccines |
Platform |
LNP Platform |
|
|
14 |
Oligonucleotide Drug Production (ASO & siRNA) |
Platform |
Nucleic Acid Drugs Production |
|
|
15 |
Oligonucleotide Delivery Platform: Novel Sequential GalNAc Linker |
Platform |
Nucleic Acid Drugs Production |
|
|
16 |
ADMET-Rescue AI Platform: From Failing Hit to Winning Lead |
Platform |
ADMET-Rescue AI Platform |
|
|
|
DCB-Asset List & Current Pipeline |
|
|